North America Alopecia Treatment (Hair Loss) Market – Industry Trends and Forecast to 2030

Inhaltsverzeichnis anfordernInhaltsverzeichnis anfordern Mit Analyst sprechen Mit Analyst sprechen Jetzt kaufenJetzt kaufen Vor dem Kauf anfragen Vorher anfragen Kostenloser Beispielbericht Kostenloser Beispielbericht

North America Alopecia Treatment (Hair Loss) Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Reports
  • Dec 2023
  • North America
  • 350 Seiten
  • Anzahl der Tabellen: 220
  • Anzahl der Abbildungen: 60

North America Alopecia Treatment Hair Loss Market

Marktgröße in Milliarden USD

CAGR :  % Diagram

Diagramm Prognosezeitraum
2023 –2030
Diagramm Marktgröße (Basisjahr)
USD 1,947.87 Million
Diagramm Marktgröße (Prognosejahr)
USD 3,081.26 Million
Diagramm CAGR
%
Diagramm Wichtige Marktteilnehmer
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

North America Alopecia Treatment (Hair Loss) Market, By Drug Type (Minoxidil, Finasteride, Others), Indication (Androgenic Alopecia, Alopecia Areata, Alopecia Totalis, Others), Diagnosis (Trichoscopy, Skin Biopsy, Others), Gender (Male, Female), Route of Administration (Oral, Topical, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) - Industry Trends and Forecast to 2030.

North America Alopecia Treatment (Hair Loss) Market

North America Alopecia Treatment (Hair Loss) Market Analysis and Size         

Alopecia is a term that refers to hair loss caused by specific medical illnesses or nutritional disorders. Hair loss is becoming more common as a result of sedentary lifestyles and unhealthy eating habits. Furthermore, hair loss is caused by ageing and hormonal imbalance and an increase in chronic diseases including arthritis, cancer, hypertension, and depression, particularly among the middle-aged population. As per the American Hair Loss Association, androgenetic alopecia accounts for almost 95 percent of hair loss in men. Over 800,000 people worldwide are looking for a solution to their hair loss.

Data Bridge Market Research analyzes that the alopecia treatment (hair loss) market which was USD 1,947.87 million in 2022, would reach up to USD 3,081.26 million by 2030, and is expected to undergo a CAGR of 5.90% during the forecast period. “Minoxidil” accounts for the largest market share in drug type segment in the alopecia treatment (hair loss) market due to the benefits it offers in treatment of hair loss. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Report Scope and Market Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015-2020)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

By Drug Type (Minoxidil, Finasteride, Others), Indication (Androgenic Alopecia, Alopecia Areata, Alopecia Totalis, Others), Diagnosis (Trichoscopy, Skin Biopsy, Others), Gender (Male, Female), Route of Administration (Oral, Topical, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others)

Countries Covered

U.S., Canada, Mexico

Market Players Covered

Johnson & Johnson Private Limited (U.S.), GlaxoSmithKline plc (UK), Merck & Co., Inc. (U.S.), Pfizer Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceutical Industries Ltd. (Ireland), Cipla Inc. (U.S.), Endo International plc (Ireland), Zydus Cadila (India), Abbott (U.S.), Aurobindo Pharma (India), Dr. Reddy’s Laboratories Ltd. (India), Perrigo Company plc (Ireland), Curallux, LLC. (U.S.), DR. KURT WOLFF GMBH & CO. KG (Germany), WOCKHARDT (India)

Market Opportunities

  • Innovation in treatment modalities
  • Rise in cosmetic procedures and clinics

Market Definition

Alopecia is an autoimmune skin condition that affects the growth of healthy hair follicles on the scalp, face, and other parts of the body. The type of alopecia areata, the patient's age, and the extent of hair loss all influence treatment. Alopecia treatment focuses on inhibiting the immune system from attacking the hair and encouraging it to regrow. Finasteride, minoxidil and cyclosporine are the alopecia treatment (hair loss) drugs which are indicated for alopecia treatment. Phototherapy, also known as low light laser therapy (LLLT), is gaining popularity around the world since it is less invasive and safer than other therapies.

North America Alopecia Treatment (Hair Loss) Market Dynamics

Drivers

  • Increasing prevalence of hair loss

The rising prevalence of hair loss is estimated to enhance the growth of the alopecia treatment (hair loss) market. In 2018, the American Academy of Dermatology Association (AAD) projected that about 50 million men and 30 million women in the United States were plagued with alopecia. According to the Journal of Clinical and Diagnostic Research (JCDR), around 60% of the population suffers from hair thinning, with pattern hair loss being the most common kind of hair loss in both men and women. Furthermore, roughly 2% of the entire population, regardless of gender, is at risk of acquiring alopecia treatment (hair loss) in their lifetime.

  • Advancements in treatment technologies

Advancements in alopecia treatment technologies, such as the development of novel medications, surgical procedures like hair transplantation, and innovative therapies like platelet-rich plasma (PRP) treatments, are key drivers of market growth. These advancements offer patients a diverse range of effective and tailored solutions, contributing to increased demand for alopecia treatments. As the field continues to evolve, patients are likely to benefit from a growing array of options that are both technologically advanced and less invasive, thereby fueling the expansion of the alopecia treatment market in North America.

Opportunities

  • Innovation in treatment modalities

The growth of the alopecia treatment market spurs innovation in pharmaceuticals, surgery, and therapies. Research and development efforts focus on creating advanced medications, surgical techniques, and therapies such as regenerative medicine to provide patients with more effective and tailored solutions, driving continuous evolution in the field.

  • Rise in cosmetic procedures and clinics

The expanding alopecia treatment market offers a growth opportunity for cosmetic clinics. Entrepreneurs can establish specialized clinics offering a range of services, including advanced surgical interventions and non-surgical treatments. This trend not only caters to the rising demand for aesthetic solutions but also creates a niche for clinics dedicated to addressing hair-related concerns.

Restraints/Challenges

  • High treatment costs

The high costs associated with certain alopecia treatments, such as hair transplantation or cutting-edge therapies, pose a significant barrier to accessibility. Affordability concerns may limit the adoption of these treatments, prompting a need for cost-effective alternatives and strategies to improve financial access for a broader patient demographic.

  • Adverse side effects

Potential side effects associated with alopecia treatments can deter patients from pursuing interventions. Balancing the benefits and risks becomes crucial, and addressing concerns related to adverse effects requires transparent communication between healthcare providers and patients. Minimizing side effects through ongoing research and development is essential for enhancing the safety profile of alopecia treatments.

This alopecia treatment (hair loss) market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the alopecia treatment (hair loss) market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Recent Development

  • In August 2021, Pfizer had announced the positive top-line results from phase 2b/3 trial of ritlecitinib in alopecia treatment (hair loss). Ritlecitinib is the first of a new class of covalent kinase inhibitors that target Janus kinase 3 (JAK3) and members of the tyrosine kinase expressed in hepatocellular carcinoma (TEC) kinase family with great selectivity. Ritlecitinib has been found in lab experiments to prevent the function of signaling molecules and immune cells that are thought to contribute to hair loss in persons with alopecia treatment (hair loss)

North America Alopecia Treatment (Hair Loss) Market Scope

The alopecia treatment (hair loss) market is segmented on the basis of drug type, indication, diagnosis, gender, route of administration, end users, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Drug Type

  • Minoxidil
  • Finasteride
  • Others

Indication

  • Androgenic Alopecia
  • Alopecia Areata
  • Alopecia Totalis
  • Others

Diagnosis

  • Trichoscopy
  • Skin Biopsy
  • Others

Gender

  • Male
  • Female

Route of Administration

  • Oral
  • Topical
  • Parenteral
  • Others

End Users

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others

North America Alopecia Treatment (Hair Loss) Market Regional Analysis/Insights

The alopecia treatment (hair loss) market is analysed and market size insights and trends are provided by country, drug type, indication, diagnosis, gender, route of administration, end users, and distribution channel as referenced above.

The countries covered in the alopecia treatment (hair loss) market report are U.S., Canada and Mexico.

U.S. is expected to dominate the alopecia treatment (hair loss) market with highest market share and growth rate in the forecast period because of the increasing prevalence of male alopecia and advancements in cosmetic procedures for its treatment.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The alopecia treatment (hair loss) market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for alopecia treatment (hair loss) market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the alopecia treatment (hair loss) market. The data is available for historic period 2010-2020.

Competitive Landscape and North America Alopecia Treatment (Hair Loss) Market Share Analysis

The alopecia treatment (hair loss) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to alopecia treatment (hair loss) market.

Some of the major players operating in the alopecia treatment (hair loss) market are:

  • Johnson & Johnson Private Limited (U.S.)
  • GlaxoSmithKline plc (UK)
  • Merck & Co., Inc. (U.S.)
  • Pfizer Inc. (U.S.)
  • Sun Pharmaceutical Industries Ltd. (India)
  • Teva Pharmaceutical Industries Ltd. (Ireland)
  • Cipla Inc. (U.S.)
  • Endo International plc (Ireland)
  • Zydus Cadila (India)
  • Abbott (U.S.)
  • Aurobindo Pharma (India)
  • Dr. Reddy’s Laboratories Ltd. (India)
  • Perrigo Company plc (Ireland)
  • Curallux, LLC. (U.S.)
  • DR. KURT WOLFF GMBH & CO. KG (Germany)
  • WOCKHARDT (India)


SKU-

Erhalten Sie Online-Zugriff auf den Bericht zur weltweit ersten Market Intelligence Cloud

  • Interaktives Datenanalyse-Dashboard
  • Unternehmensanalyse-Dashboard für Chancen mit hohem Wachstumspotenzial
  • Zugriff für Research-Analysten für Anpassungen und Abfragen
  • Konkurrenzanalyse mit interaktivem Dashboard
  • Aktuelle Nachrichten, Updates und Trendanalyse
  • Nutzen Sie die Leistungsfähigkeit der Benchmark-Analyse für eine umfassende Konkurrenzverfolgung
Demo anfordern

Forschungsmethodik

Die Datenerfassung und Basisjahresanalyse werden mithilfe von Datenerfassungsmodulen mit großen Stichprobengrößen durchgeführt. Die Phase umfasst das Erhalten von Marktinformationen oder verwandten Daten aus verschiedenen Quellen und Strategien. Sie umfasst die Prüfung und Planung aller aus der Vergangenheit im Voraus erfassten Daten. Sie umfasst auch die Prüfung von Informationsinkonsistenzen, die in verschiedenen Informationsquellen auftreten. Die Marktdaten werden mithilfe von marktstatistischen und kohärenten Modellen analysiert und geschätzt. Darüber hinaus sind Marktanteilsanalyse und Schlüsseltrendanalyse die wichtigsten Erfolgsfaktoren im Marktbericht. Um mehr zu erfahren, fordern Sie bitte einen Analystenanruf an oder geben Sie Ihre Anfrage ein.

Die wichtigste Forschungsmethodik, die vom DBMR-Forschungsteam verwendet wird, ist die Datentriangulation, die Data Mining, die Analyse der Auswirkungen von Datenvariablen auf den Markt und die primäre (Branchenexperten-)Validierung umfasst. Zu den Datenmodellen gehören ein Lieferantenpositionierungsraster, eine Marktzeitlinienanalyse, ein Marktüberblick und -leitfaden, ein Firmenpositionierungsraster, eine Patentanalyse, eine Preisanalyse, eine Firmenmarktanteilsanalyse, Messstandards, eine globale versus eine regionale und Lieferantenanteilsanalyse. Um mehr über die Forschungsmethodik zu erfahren, senden Sie eine Anfrage an unsere Branchenexperten.

Anpassung möglich

Data Bridge Market Research ist ein führendes Unternehmen in der fortgeschrittenen formativen Forschung. Wir sind stolz darauf, unseren bestehenden und neuen Kunden Daten und Analysen zu bieten, die zu ihren Zielen passen. Der Bericht kann angepasst werden, um Preistrendanalysen von Zielmarken, Marktverständnis für zusätzliche Länder (fordern Sie die Länderliste an), Daten zu klinischen Studienergebnissen, Literaturübersicht, Analysen des Marktes für aufgearbeitete Produkte und Produktbasis einzuschließen. Marktanalysen von Zielkonkurrenten können von technologiebasierten Analysen bis hin zu Marktportfoliostrategien analysiert werden. Wir können so viele Wettbewerber hinzufügen, wie Sie Daten in dem von Ihnen gewünschten Format und Datenstil benötigen. Unser Analystenteam kann Ihnen auch Daten in groben Excel-Rohdateien und Pivot-Tabellen (Fact Book) bereitstellen oder Sie bei der Erstellung von Präsentationen aus den im Bericht verfügbaren Datensätzen unterstützen.

Häufig gestellte Fragen

The North America Alopecia Treatment (Hair Loss) Market will be worth USD 3,081.26 million in the forecast period by 2030.
The North America Alopecia Treatment (Hair Loss) Market growth rate is 5.90% during the forecast period.
Increasing prevalence of hair loss and Advancements in treatment technologies are the growth drivers of the North America Alopecia Treatment (Hair Loss) Market.
The drug type, indication, diagnosis, gender, route of administration, end users, and distribution channel are the factors on which the North America Alopecia Treatment (Hair Loss) Market research is based.
Major companies in the North America Alopecia Treatment (Hair Loss) Market are Johnson & Johnson Private Limited (U.S.), GlaxoSmithKline plc (UK), Merck & Co., Inc. (U.S.), Pfizer Inc. (U.S.), Sun Pharmaceutical Industries Ltd. (India), Teva Pharmaceutical Industries Ltd. (Ireland), Cipla Inc. (U.S.), Endo International plc (Ireland), Zydus Cadila (India), Abbott (U.S.), Aurobindo Pharma (India), Dr. Reddy’s Laboratories Ltd. (India), Perrigo Company plc (Ireland), Curallux, LLC. (U.S.), DR. KURT WOLFF GMBH & CO. KG (Germany), WOCKHARDT (India).